Fiduciary Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.93M Buy
13,843
+86
+0.6% +$12K 0.02% 287
2025
Q4
$1.69M Buy
13,757
+125
+0.9% +$15.2K 0.02% 311
2025
Q3
$1.51M Buy
13,632
+34
+0.3% +$3.87K 0.02% 336
2025
Q2
$1.51M Buy
13,598
+801
+6% +$85.2K 0.02% 321
2025
Q1
$1.43M Buy
12,797
+150
+1% +$15.5K 0.02% 325
2024
Q4
$1.17M Sell
12,647
-777
-6% -$70K 0.02% 328
2024
Q3
$1.13M Buy
13,424
+2,807
+26% +$214K 0.02% 344
2024
Q2
$728K Sell
10,617
-4,071
-28% -$272K 0.01% 386
2024
Q1
$1.08M Sell
14,688
-417
-3% -$32.1K 0.02% 336
2023
Q4
$1.22M Sell
15,105
-743
-5% -$57.8K 0.02% 299
2023
Q3
$1.19M Buy
15,848
+730
+5% +$56.1K 0.02% 292
2023
Q2
$1.17M Sell
15,118
-1,247
-8% -$99.5K 0.02% 310
2023
Q1
$1.36M Sell
16,365
-290
-2% -$24K 0.03% 276
2022
Q4
$1.43M Sell
16,655
-384
-2% -$30.4K 0.03% 284
2022
Q3
$1.05M Sell
17,039
-120
-0.7% -$7.57K 0.02% 312
2022
Q2
$1.06M Sell
17,159
-458
-3% -$28.4K 0.02% 319
2022
Q1
$1.05M Sell
17,617
-280
-2% -$17.9K 0.02% 338
2021
Q4
$1.3M Sell
17,897
-563
-3% -$38.8K 0.02% 307
2021
Q3
$1.29M Sell
18,460
-986
-5% -$69.3K 0.02% 292
2021
Q2
$1.34M Sell
19,446
-1,268
-6% -$84.7K 0.03% 292
2021
Q1
$1.34M Buy
20,714
+285
+1% +$18.4K 0.03% 286
2020
Q4
$1.19M Sell
20,429
-12,147
-37% -$733K 0.02% 299
2020
Q3
$2.06M Sell
32,576
-1,104
-3% -$76.6K 0.05% 213
2020
Q2
$2.59M Buy
33,680
+1,016
+3% +$77.9K 0.06% 185
2020
Q1
$2.44M Sell
32,664
-2,375
-7% -$164K 0.07% 171
2019
Q4
$2.28M Sell
35,039
-4,055
-10% -$264K 0.05% 196
2019
Q3
$2.48M Sell
39,094
-3,364
-8% -$220K 0.06% 186
2019
Q2
$2.87M Sell
42,458
-3,834
-8% -$252K 0.08% 167
2019
Q1
$3.01M Sell
46,292
-10,395
-18% -$691K 0.08% 155
2018
Q4
$3.55M Sell
56,687
-25,025
-31% -$1.75M 0.11% 135
2018
Q3
$6.31M Sell
81,712
-4,224
-5% -$319K 0.18% 109
2018
Q2
$6.09M Sell
85,936
-5,596
-6% -$395K 0.18% 112
2018
Q1
$6.9M Sell
91,532
-9,754
-10% -$775K 0.21% 102
2017
Q4
$7.26M Sell
101,286
-16,525
-14% -$1.25M 0.22% 101
2017
Q3
$9.54M Sell
117,811
-13,977
-11% -$1.07M 0.29% 85
2017
Q2
$9.33M Sell
131,788
-25,191
-16% -$1.68M 0.29% 85
2017
Q1
$10.7M Sell
156,979
-23,329
-13% -$1.64M 0.33% 79
2016
Q4
$12.9M Sell
180,308
-39,939
-18% -$2.97M 0.42% 64
2016
Q3
$17.4M Buy
220,247
+37,523
+21% +$3.05M 0.6% 51
2016
Q2
$15.2M Buy
182,724
+4,827
+3% +$428K 0.54% 56
2016
Q1
$16.3M Buy
177,897
+22,130
+14% +$2M 0.58% 52
2015
Q4
$15.8M Buy
155,767
+5,470
+4% +$569K 0.67% 48
2015
Q3
$14.8M Buy
150,297
+23,581
+19% +$2.62M 0.67% 47
2015
Q2
$14.8M Sell
126,716
-511
-0.4% -$55.8K 0.62% 51
2015
Q1
$12.5M Buy
127,227
+7,179
+6% +$729K 0.52% 61
2014
Q4
$11.3M Buy
120,048
+19,001
+19% +$1.97M 0.48% 62
2014
Q3
$10.8M Buy
101,047
+10,725
+12% +$1.05M 0.47% 62
2014
Q2
$7.49M Buy
90,322
+50,260
+125% +$3.91M 0.32% 80
2014
Q1
$2.84M Buy
40,062
+26,326
+192% +$2.06M 0.13% 130
2013
Q4
$1.03M Buy
13,736
+2,345
+21% +$163K 0.05% 176
2013
Q3
$716K Sell
11,391
-800
-7% -$47.8K 0.03% 193
2013
Q2
$625K Buy
+12,191
New +$635K 0.03% 200

Other funds holding GILD

Fiduciary Trust's GILD Position: Q1 2026 in Review

Fiduciary Trust increased its Gilead Sciences (GILD) stake by 0.63% in Q1 2026, buying an estimated $12K and bringing the position to 13,843 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #287.

Fiduciary Trust first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.4M in Q3 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Fiduciary Trust held 13,843 shares of Gilead Sciences worth $1.93M as of Q1 2026.
  • Fiduciary Trust bought 86 Gilead Sciences shares in Q1 2026, an estimated $12K.
  • Gilead Sciences made up 0.02% of Fiduciary Trust's portfolio in Q1 2026, its #287 holding.
  • Fiduciary Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's Gilead Sciences position peaked at $17.4M in Q3 2016.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.